SecurityTSX:ATD.B / Alimentation Couche-Tard
Institutional Owners129 (129 N-Q Owners)

Institutional Stock Ownership and Shareholders

Alimentation Couche-Tard (TSX:ATD.B) has 129 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). Largest shareholders include .

Alimentation Couche-Tard (TSX:ATD.B) ownership summary shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.


Important Note!
Note: We do not currently have a CUSIP on file for this security. That means we are unable to search institutional fund filings (13F's) for this company, which means there may be institutional holders that we are unaware of. If you know the CUSIP or would like us to research and update this security, please let us know by leaving a message in the Welcome Group.
File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-02-28 N-Q Goldman Sachs Trust (see advisory)
2017-11-29 N-Q HARTFORD SERIES FUND INC (see advisory)
2017-09-27 N-Q Advisors' Inner Circle Fund Ii (see advisory)
2017-11-29 N-Q Deutsche Variable Series Ii (see advisory)
2018-01-29 N-Q American Beacon Funds (see advisory)
2017-09-28 N-Q Vanguard Star Funds (see advisory)
2018-01-25 N-Q Putnam Investment Funds (see advisory)
2018-02-28 N-Q Virtus Opportunities Trust (see advisory)
2017-11-21 N-Q Penn Series Funds Inc (see advisory)
2018-02-26 N-Q Blackrock Funds Ii (see advisory)
2017-09-25 N-Q Alpine Global Dynamic Dividend Fund (see advisory)
2018-03-01 N-Q First Investors Equity Funds (see advisory)
2017-09-27 N-Q American Independence Funds Trust (see advisory)
2018-02-28 N-Q Advisers Investment Trust (see advisory)
2017-11-29 N-Q Amg Funds Iii (see advisory)
2017-09-29 N-Q Putnam Income Fund (see advisory)
2018-03-01 N-Q Oppenheimer Global Strategic Income Fund (see advisory)
2018-02-28 N-Q Morgan Stanley Institutional Fund Trust (see advisory)
2017-09-28 N-Q Mfs Intermediate Income Trust (see advisory)
2018-01-23 N-Q Mfs Series Trust Iv (see advisory)
2017-09-28 N-Q Fidelity Investment Trust (see advisory)
2018-03-01 N-Q Loomis Sayles Funds Ii (see advisory)
2017-11-17 N-Q Lazard Retirement Series Inc (see advisory)
2017-09-28 N-Q Fidelity Charles Street Trust (see advisory)
2017-11-14 N-Q Wright Managed Equity Trust (see advisory)
2017-09-27 N-Q Advisors' Inner Circle Fund Iii (see advisory)
2018-02-28 N-Q Seasons Series Trust (see advisory)
2017-09-28 N-Q Powershares Exchange-traded Fund Trust Ii (see advisory)
2017-09-29 N-Q Oppenheimer Global Multi-asset Growth Fund (see advisory)
2018-02-28 N-Q EUROPACIFIC GROWTH FUND (see advisory)
2017-09-27 N-Q Scm Trust (see advisory)
2017-12-27 N-Q Pioneer Series Trust Iv (see advisory)
2018-03-15 N-Q Tcw Funds Inc (see advisory)
2018-01-23 N-Q Schwab Strategic Trust (see advisory)
2017-11-22 N-Q Elfun Diversified Fund (see advisory)
2017-12-28 N-Q Entrepreneurshares Series Trust (see advisory)
2018-01-25 N-Q Usaa Etf Trust (see advisory)
2017-11-28 N-Q Morgan Stanley Variable Investment Series (see advisory)
2017-12-28 N-Q George Putnam Balanced Fund (see advisory)
2018-01-29 N-Q Invesco Bond Fund (see advisory)
2018-02-27 N-Q Pioneer Series Trust X (see advisory)
2018-01-29 N-Q Goldman Sachs Etf Trust (see advisory)
2018-01-29 N-Q Oppenheimer Limited-term Bond Fund (see advisory)
2017-11-24 N-Q Transamerica Series Trust (see advisory)
2018-01-29 N-Q Aim Investment Securities Funds (invesco Investment Securities Funds) (see advisory)
2017-09-25 N-Q Alpine Series Trust (see advisory)
2017-09-29 N-Q Oppenheimer Quest For Value Funds (see advisory)
2018-02-28 N-Q Metropolitan West Funds (see advisory)
2017-11-27 N-Q Voya Variable Insurance Trust (see advisory)
2018-02-23 N-Q Blackrock Funds (see advisory)
2017-11-27 N-Q Goldman Sachs Variable Insurance Trust (see advisory)
2018-02-28 N-Q NEW PERSPECTIVE FUND (see advisory)
2018-02-27 N-Q Northern Funds (see advisory)
2017-09-29 N-Q John Hancock Income Securities Trust (see advisory)
2018-01-25 N-Q Federated Institutional Trust (see advisory)
2018-01-29 N-Q Neuberger Berman Equity Funds (see advisory)
2017-11-27 N-Q John Hancock Variable Insurance Trust (see advisory)
2017-09-29 N-Q Alger Funds (see advisory)
2017-09-25 N-Q Alpine Total Dynamic Dividend Fund (see advisory)
2018-03-01 N-Q Sei Institutional Managed Trust (see advisory)
2017-10-30 N-Q John Hancock Sovereign Bond Fund (see advisory)
2017-09-28 N-Q Fidelity Salem Street Trust (see advisory)
2017-10-30 N-Q Copeland Trust (see advisory)
2018-02-27 N-Q Federated Total Return Series Inc (see advisory)
2018-02-28 N-Q Wells Fargo Funds Trust (see advisory)
2017-10-27 N-Q Putnam Funds Trust (see advisory)
2017-10-20 N-Q Strategic Funds, Inc. (see advisory)
2018-03-01 N-Q Spdr Index Shares Funds (formerly Streettracks Index Shares Funds) (see advisory)
2018-02-27 N-Q Lattice Strategies Trust (see advisory)
2018-02-28 N-Q Pacific Funds Series Trust (see advisory)
2018-02-27 N-Q Putnam Asset Allocation Funds (see advisory)
2017-09-28 N-Q CAPITAL INCOME BUILDER (see advisory)
2017-11-28 N-Q American Funds Insurance Series (see advisory)
2018-02-28 N-Q Wisdomtree Trust (see advisory)
2017-09-28 N-Q Harding Loevner Funds Inc (see advisory)
2017-10-30 N-Q Vanguard Wellington Fund (see advisory)
2017-09-28 N-Q Delaware Pooled Trust (see advisory)
2017-12-20 N-Q Td Asset Management Usa Funds Inc. (see advisory)
2017-10-30 N-Q Oppenheimer International Growth Fund (see advisory)
2018-01-26 N-Q Fidelity Select Portfolios (see advisory)
2017-09-20 N-Q Dreyfus Opportunity Funds (see advisory)
2018-01-26 N-Q Brinker Capital Destinations Trust (see advisory)
2018-02-28 N-Q State Street Institutional Funds (see advisory)
2017-11-28 N-Q Pacific Select Fund (see advisory)
2017-09-29 N-Q John Hancock Investment Trust (see advisory)
2017-11-27 N-Q Voya Balanced Portfolio Inc (see advisory)
2017-09-22 N-Q Nationwide Mutual Funds (see advisory)
2018-01-24 N-Q Deutsche Global/international Fund, Inc. (see advisory)
2017-10-27 N-Q Ab Global Risk Allocation Fund, Inc. (see advisory)
2017-09-28 N-Q Fidelity Advisor Series Viii (see advisory)
2017-10-24 N-Q Federated Global Allocation Fund (see advisory)
2018-02-28 N-Q Ishares Trust (see advisory)
2017-11-22 N-Q General Electric Rsp Income Fund (see advisory)
2018-01-25 N-Q Dbx Etf Trust (see advisory)
2017-11-22 N-Q Elfun Income Fund (see advisory)
2017-11-24 N-Q Pioneer Variable Contracts Trust /ma/ (see advisory)
2018-02-27 N-Q Thornburg Investment Trust (see advisory)
2017-11-27 N-Q Voya Intermediate Bond Portfolio (see advisory)
2017-12-28 N-Q Vanguard Fixed Income Securities Funds (see advisory)
2018-03-01 N-Q Aqr Funds (see advisory)
2018-03-01 N-Q Loomis Sayles Funds I (see advisory)
2018-02-28 N-Q Franklin Templeton Etf Trust (see advisory)
2018-02-27 N-Q Pioneer Strategic Income Fund (see advisory)
2018-02-28 N-Q Vanguard Malvern Funds (see advisory)
2017-09-28 N-Q Bbh Trust (see advisory)
2018-02-26 N-Q Allianz Funds Multi-strategy Trust (see advisory)
2018-03-08 N-Q Calamos Investment Trust/il (see advisory)
2017-11-28 N-Q Variable Insurance Products Fund Ii (see advisory)
2017-11-21 N-Q Neuberger Berman Advisers Management Trust (see advisory)
2018-02-27 N-Q Massmutual Premier Funds (see advisory)
2018-03-01 N-Q Pimco Funds (see advisory)
2017-09-27 N-Q Pioneer Series Trust Vii (see advisory)
2017-10-30 N-Q Delaware Enhanced Global Dividend & Income Fund (see advisory)
2017-09-26 N-Q Legg Mason Etf Investment Trust (see advisory)
2018-02-28 N-Q Gps Funds I (see advisory)
2017-11-28 N-Q Putnam Variable Trust (see advisory)
2017-09-28 N-Q Delaware Group Adviser Funds (see advisory)
2018-02-28 N-Q Morgan Stanley Income Securities Inc (see advisory)
2018-02-28 N-Q Ivy Funds (see advisory)
2018-02-27 N-Q Massmutual Select Funds (see advisory)
2017-09-29 N-Q Putnam Global Income Trust (see advisory)
2018-01-26 N-Q Bny Mellon Funds Trust (see advisory)
2018-02-27 N-Q Federated Income Securities Trust (see advisory)
2017-11-24 N-Q Pioneer Bond Fund /de/ (see advisory)
2018-01-26 N-Q Eaton Vance Special Investment Trust (see advisory)
2017-11-27 N-Q Lazard Funds Inc (see advisory)
2018-03-01 N-Q Sei Institutional International Trust (see advisory)
2018-03-01 N-Q Calvert Responsible Index Series, Inc. (see advisory)
2017-09-28 N-Q Vanguard Charlotte Funds (see advisory)

Form N-Q Advisory - Experimental Feature Here!

We have recently started to include coverage of N-Q filers in our ownership database. N-Q forms are unstructured and difficult for machines to parse into accurate financial data.

However, Because of the large number of these institutions and this difficulty in tracking their positions, they represent a significant, yet hidden, market force. In an effort to widen our ownership coverage and provide greater transparency, we are testing various ways to expose these owners in an accurate manner. This early version of the crawler simply identifies mentions of companies in the N-Q forms.

Limitations:

  • We only list underlying securities (the ordinary shares), even though the actual security held might be a derivative or a related bond issue. For example, although the institution is shown on this security page ( TSX:ATD.B / Alimentation Couche-Tard ), the institution may actually own a related security such as a preferred share or a bond. To find out the exact security, click on the institution link and then follow the link to the actual "N-Q".
  • We only list fund sponsors as institutions, even though the security might be held within a fund operated by the listed institution.. For example, the institution listed in the table as the owner is probably a sponsor of a family of ETFs or mutual funds. If so, then this security is owned by a fund or several funds within the family, and not directly owned by the listed institution. The crawler is not yet able to place these holdings within the individual funds. Atain, you must review the actual filing to see the detail.

These limitations are significant but we believe that the increased transparency outweights the limitations. Future revisions of the crawler will resolve these limitations. Use this information at your own risk!

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...